Literature DB >> 1796823

The distribution of IgG subclass autoantibodies in bullous pemphigoid analysed by immunofluorescence and immunoblotting.

H Soh1, H Hosokawa, H Miyauchi, H Izumi, Y Asada.   

Abstract

The distribution of IgG subclasses in bullous pemphigoid (BP) autoantibodies in 14 BP sera and four biopsies was analysed by immunofluorescence (IF) and immunoblotting (IB). Three clones of monoclonal antibodies (MoAbs) to each IgG subclass were used. All 14 sera showed linear fluorescence in the basement membrane zone with IF, and 240 kDa and/or 180 kDa protein bands in human epidermal extract were detected by IB using a polyclonal antibody to total IgG. BP antibody in IgG4 subclass was found to be predominant, as it was detected most frequently and intensively in all positive sera and lesions studied by both techniques. In the IgG1 to IgG3 subclasses, a range of proportions of positive sera was obtained among MoAbs to the same IgG subclass in both techniques. However, one MoAb could detect IgG1 subclass BP antibody with a high frequency in both techniques. No difference in IgG subclass distribution of BP antibodies was observed during the course of the disease. In each serum, any IgG subclass of BP antibody recognized the identical BP antigen(s). These results suggest the predominance of IgG4 subclass and the possible presence of IgG1 subclass in BP antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796823     DOI: 10.1007/BF00371823

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

1.  The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody.

Authors:  S E Kelly; R Cerio; B S Bhogal; M M Black
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

2.  Immunoglobulin light and heavy chain isotypes in skin diseases: restricted distribution in bullous pemphigoid and linear IgA bullous dermatosis.

Authors:  T J Flotte; L G Baird
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

4.  Subclass distribution of IgG autoantibodies in bullous pemphigoid.

Authors:  P Bird; P S Friedmann; N Ling; A G Bird; R A Thompson
Journal:  J Invest Dermatol       Date:  1986-01       Impact factor: 8.551

5.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

Authors:  R Jefferis; C B Reimer; F Skvaril; G de Lange; N R Ling; J Lowe; M R Walker; D J Phillips; C H Aloisio; T W Wells
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

6.  Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies.

Authors:  E Asbrink; A Hovmark
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

7.  Isolation and purification of a pemphigus vulgaris antigen from human epidermis.

Authors:  L L Peterson; K D Wuepper
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Clinical, histological and immunological studies in 50 patients with bullous pemphigoid.

Authors:  S M Hadi; R S Barnetson; D J Gawkrodger; U Saxena; P Bird; T G Merrett
Journal:  Dermatologica       Date:  1988

9.  Identification and partial characterization of pemphigoid antigen extracted from normal human skin.

Authors:  J R Stanley; D T Woodley; S I Katz
Journal:  J Invest Dermatol       Date:  1984-01       Impact factor: 8.551

10.  IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.

Authors:  H Yamada; T Hashimoto; T Nishikawa
Journal:  J Invest Dermatol       Date:  1989-04       Impact factor: 8.551

View more
  1 in total

1.  IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

Authors:  R F Ghohestani; E Cozzani; E Delaporte; J F Nicolas; A Parodi; A Claudy
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.